I actually think lenz is better than a vaccine.
Yet, here we are with vaccines for everybody, starting at the age of 6 months.
Standard of care should be an infusion of lenz, with an activating agent, such as used in the traditional vaccines.
It makes far more sense to program an appropriate immune response to a respiratory infection, whether it is viral, fungal, parasitic, or bacterial in nature.
We're not there, yet. Lenz may be there, but we're not.
We'll take each victory as it comes. We know that the CMML trial data is revolutionary. Combine that with the recall of our loaned shares, and our success will be manifested. As far as I'm concerned, that is nothing more than a factual assessment of our situation.